Limestone Investment Advisors »

Viking Therapeutics shares owned by Limestone Investment Advisors

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Limestone Investment Advisors from 13F filings

Historical chart of Limestone Investment Advisors investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Limestone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Limestone Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 43k 26.28

More positions owned by Limestone Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Goldman Sachs Call Option (GS)
JPMorgan Chase & Co. Call Option (JPM)
Citigroup Com New Call Option (C)
Alphabet Cap Stk Cl A (GOOGL)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Netflix (NFLX)
Wells Fargo & Company Call Option (WFC)
Bank of America Corporation Call Option (BAC)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)

View all positions for Limestone Investment Advisors

Top funds holding Viking Therapeutics

Vanguard Group
Susquehanna International
FMR
BlackRock
State Street Corporation
Citadel Advisors
Morgan Stanley
Jpmorgan Chase & Co
Ameriprise Financial
Two Sigma Investments
Jane Street
Geode Capital Management
Two Sigma Advisers
UBS Group
Pictet Asset Management Holding SA

View all funds holding Viking Therapeutics